Proteomics

Dataset Information

0

The pivotal and universal role of BGLT3 lncRNA in fetal globin gene expression


ABSTRACT: A highly selective and non-genotoxic G9a inhibitor, RK-701 was discovered, which upregulated the mRNA level of γ-globin but not β-globin both in human erythroid cells and in mice. Using RK-701, we examined the induction of the fetal (γ-) globin protein in human erythroid cells; HUDEP-2 and human CD34+ bone marrow and peripheral blood cells.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Erythrocyte, Cell Culture

DISEASE(S): Sickle Cell Anemia

SUBMITTER: Masaya Usui  

LAB HEAD: Akihiro Ito

PROVIDER: PXD033536 | Pride | 2023-03-11

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
210305_QE_18_152_Shirai_HUDEP_HbFI_2uL.raw Raw
F211363.dat Other
F211363.mgf Mgf
F211363.mzid.gz Mzid
Items per page:
1 - 4 of 4
altmetric image

Publications


Sickle cell disease (SCD) is a heritable disorder caused by β-globin gene mutations. Induction of fetal γ-globin is an established therapeutic strategy. Recently, epigenetic modulators, including G9a inhibitors, have been proposed as therapeutic agents. However, the molecular mechanisms whereby these small molecules reactivate γ-globin remain unclear. Here we report the development of a highly selective and non-genotoxic G9a inhibitor, RK-701. RK-701 treatment induces fetal globin expression bot  ...[more]

Similar Datasets

2024-12-10 | GSE264491 | GEO
2023-04-28 | GSE228819 | GEO
2017-11-01 | GSE105035 | GEO
2013-02-16 | E-GEOD-42078 | biostudies-arrayexpress
2020-01-23 | PXD006889 | Pride
2022-02-16 | PXD024259 | Pride
2017-04-13 | GSE97671 | GEO
2020-04-17 | GSE143962 | GEO
2020-04-17 | GSE143961 | GEO
2012-08-19 | E-GEOD-31523 | biostudies-arrayexpress